The Global Precision Medicine Market is estimated to gain a valuation of USD 132.66 billion by 2027, expanding at a CAGR of 10.3%, according to the current analysis by Emergen Research. The proliferation of sequencing methodologies, such as Next Generation Sequencing (NGS), and rapid advancement in the Human Genome Project in the genomics field, is anticipated to drive the market growth.
The increasing incidences of chronic and rare diseases augment the need for technologically innovative methods for accelerated collection and analysis of data. The bioinformatics programs assess in the data processing that leads to the development of successful therapeutic approaches. This can lead to the generation of massive amounts of data in the healthcare sector, thereby fueling the demand for bioinformatics, raising competition for precision medicine.
Development of advanced bioinformatics tools and applications is anticipated to promote immunotherapy production, boosting the microbiome studies, thus leading to the expansion of precision medicine. Additionally, the development of high-throughput technologies such as NGS and microarray are anticipated to break the ground for bioinformatics, driving the market growth over the projected timeframe.
Claim Your FREE Sample Copy with Table of content
Key Highlights from the Report:
- Based on technology, drug discovery is estimated to expand at a CAGR of 9.8% in the projected period due to the increasing focus of biopharmaceutical companies in developing precision medicine to treat rare and chronic diseases, including cancer.
- Diagnostic companies are anticipated to proliferate at the highest growth rate, registering a CAGR of 10.4% during the timespan. This growth can be attributed to the broad spectrum of applications of the precision medicine industry and the active engagement of market players in the market’s advancement.
- The Oncology application holds significant weight in the Precision Medicine Market owing to the rising incidences of cancer worldwide, intensifying the demand for precision medicine. Precision medicine plays a pivotal part in the cancer treatment as it can develop tailored therapies for cancer patients depending on their genetic makeup.
- North America accounted for the largest industry share in 2019 and is expected to continue its dominance. This can be accredited to the consistent focus on developing cost-efficient and innovative procedures and the presence of major market players in the region.
- Qiagen, NanoString Technologies, Biocrates Life Sciences, Novartis, Teva Pharmaceutical, Tepnel Pharma Services, Menarini Silicon Biosystems, Quest Diagnostics, Eagle Genomics, and Pfizer, among others are some of the prominent players in the market.
Check Our Prices@ https://www.emergenresearch.com/select-license/32
For the purpose of this report, Emergen Research has segmented the global Precision Medicine Market on the basis of technology, end-use, application, and region:
Technology Outlook (Revenue, USD Billion; 2017-2027)
- Bioinformatics
- Big Data Analytics
- Gene Sequencing
- Companion Diagnostics
- Drug Discovery
- Others
End-Use Outlook (Revenue, USD Billion; 2017-2027)
- Pharmaceutical Companies
- Healthcare IT companies
- Diagnostic Companies
- Others
Application Outlook (Revenue, USD Billion; 2017-2027)
- CNS
- Oncology
- Respiratory
- Immunology
- Others
Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends
Regional Outlook (Revenue, USD Billion; 2017-2027)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- Rest of MEA
Insights into our Other Published Healthcare Reports:
Tissue Imaging Market Size To Be Worth USD 27.32 Billion by 2027
Virtual Diagnostics Market Size To Be Worth USD 1,512.2 Million by 2027 Growing at a CAGR of 15.0%
Anti-Aging Devices Market Size To Be Worth USD 14.22 Billion by 2027
Mobile Medical Apps Market Size Worth USD 17.61 Billion by 2027 Growing at a CAGR of 22.9%
Asthma Spacers Market Size To Be Worth USD 2.38 Billion by 2027 Growing at a CAGR of 3.4%
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkedIn | Twitter | Blogs
Read Full Press Release@ https://www.emergenresearch.com/press-release/global-precision-medicine-market
